MOBILE, Ala., Jan. 13, 2011 /PRNewswire/ -- HASCO Medical, Inc. (OTC Bulletin Board: HASC), www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, today announced that Southern Medical & Mobility (SMM), a wholly owned subsidiary of HASCO Medical, has signed an agreement with an entity of the State of Alabama.
Under terms of the agreement, SMM will be providing high-end rehabilitation chairs and medical equipment to pediatric patients throughout Southern Alabama. The contract is expected to exceed several hundred thousand dollars and broaden the customer base for the entire SMM product line.
Mr. Hal Compton, Jr., SMM CEO, stated, "We were able to leverage our expertise in the medical mobility field to land a contract directly with the State of Alabama. It is expected that as we deliver a world-class product and service, that we can expand across the entire state and then leverage our experience to neighboring states across the U.S. We look forward to providing the State of Alabama with top-of-the-line service, especially to those pediatric patients in need."
About HASCO Medical, Inc.
HASCO Medical, Inc., is a managed healthcare provider of a broad range of home healthcare services that serve patients in Alabama, Florida, and Mississippi. The Company has two major service lines: home respiratory equipment and durable/ home medical equipment. The Company's objective is to be a leading provider of home health care products and services in the continental United States.
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
|SOURCE HASCO Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved